American pharmaceutical giant Pfizer is conducting clinical trials with German firm BioNTech on several probable vaccines in Europe and the United States. The drugmaker has announced that a Coronavirus vaccine could be ready by October-end.
“If things go well, and the stars are aligned, we will have enough evidence of safety and efficacy so that we can… have a vaccine around the end of October,” Albert Bourla, the CEO of the company revealed to an Israel based Newspaper much to the delight of the population across the globe.
.
The contagious virus has claimed more than 3.5 lakh lives and infected over 5 million people globally so far. There is no sight of normalcy in the near future. Across the globe, over 100 labs are working to develop a vaccine against coronavirus. Only ten vaccine candidates have reached the clinical trial phase.
In India, there are around 1.7 Lakh confirmed cases and there are close to 5,000 deaths.
